Supplementary Tables
Absolute measurements (mean ± SEM; in mm) of the abdominal aortic diameter using B-mode ultrasound from the porcine-pancreatic-elastase (PPE) induction model from baseline until day 28. Absolute measurements correspond to Figure 1A (presented as AAD vs. baseline in %) in the manuscript. P < 0.05 is considered significant vs. same-day sham, using Student's t-test for parametric measures (*). Absolute measurements (mean ± SEM; in mm) of the abdominal aortic diameter using B-mode ultrasound from the porcine-pancreatic-elastase (PPE) induction model from baseline until day 28 in anti-/pre-24 and scr-miR mice with AAA. Absolute measurements correspond to Figure 4B (presented as AAD vs. baseline in %) in the manuscript. P < 0.05 is considered significant, using one-way ANOVA with Bonferroni's post-test (*). Blood pressure measurements (systolic/diastolic) in otherwise-untreated miR-24-modulated mice (anti-and pre-24 compared to scr-miR). Data are mean ± SEM. P < 0.05 is considered significant, using one-way ANOVA with Bonferroni's post-test. Scr-miR (scrambled-miR-injected mouse with PPE-induced AAA); pre-24 (pre-miR-24 transduced mice with PPE-induced AAA); VSMC (vascular smooth muscle cells); ECM (extracellular matrix). Numbers of differentially regulated genes in each pathway at day 7 post-AAA induction shown. See Supplementary Note 1 for details. Data are mean ± standard deviation (SD), number (n) of individuals and percentages (%). P < 0.05 is considered significant (*), using ANOVA with Bonferroni's post test for parametric data with normal distribution. For categorical, non-parametric data (smoking status and medication), Chi-squared test (χ 2 ) was utilized. AAA (abdominal aortic aneurysm); AAD (abdominal aortic diameter measured by ultrasound); ACEI (angiotensin converting enzyme inhibitor); ARB (angiotensin II receptor blocker); ASAT (aspartate aminotransferase); eGFR (estimated glomerular filtration rate), HbA1c (glycosylated hemoglobin); PVOD (peripheral vascular occlusive disease); NSAID (non-steroidal anti-inflammatory drug).
